CollPlant Biotechnologies Ltd., headquartered in Israel, is a pioneering company in the regenerative medicine and tissue engineering sectors. Founded in 2004, CollPlant has made significant strides in developing innovative solutions for wound healing and organ regeneration, leveraging its proprietary recombinant human collagen technology.
The company’s core products include advanced wound care solutions and potential therapeutic applications for various medical conditions. What sets CollPlant apart is its unique ability to produce collagen through a plant-based system, ensuring a sustainable and biocompatible alternative to animal-derived collagen.
With a strong market position, CollPlant has garnered attention for its groundbreaking research and development efforts, positioning itself as a leader in the biotechnology industry. Its commitment to enhancing patient outcomes through cutting-edge technology continues to drive its growth and influence in the field.
-18 vs industry average
CollPlant’s score of 20 is lower than 35% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at CollPlant?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
CollPlant's reported carbon emissions
In 2023, CollPlant Biotechnologies Ltd., headquartered in Israel (IL), reported total emissions of approximately 457,636.4 kg CO2e. This figure includes 74,588.2 kg CO2e from Scope 1 emissions and 383,048.2 kg CO2e from Scope 2 emissions. Notably, the company has not disclosed any Scope 3 emissions data. Comparatively, in 2022, CollPlant's total emissions were approximately 439,930.0 kg CO2e, with Scope 1 and Scope 2 emissions of 71,860.0 kg CO2e and 368,070.0 kg CO2e, respectively. This indicates a slight increase in total emissions from 2022 to 2023. CollPlant has not set specific reduction targets or initiatives as part of its climate commitments, nor does it participate in initiatives such as the Science Based Targets initiative (SBTi). The company has not disclosed any climate pledges or reduction initiatives, indicating a potential area for future development in its sustainability strategy. Overall, while CollPlant has made strides in tracking its emissions, the absence of reduction targets suggests an opportunity for enhanced climate action and commitment to sustainability.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
CollPlant’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for CollPlant yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
CollPlant
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project